Literature DB >> 844244

High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension.

L J Beilin, F S Goldby, J Mohring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844244     DOI: 10.1042/cs0520111

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


× No keyword cloud information.
  10 in total

Review 1.  Immune Mechanisms in Arterial Hypertension.

Authors:  Ulrich Wenzel; Jan Eric Turner; Christian Krebs; Christian Kurts; David G Harrison; Heimo Ehmke
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.

Authors:  Karen A Griffin; Aaron Polichnowski; Natalia Litbarg; Maria Picken; Manjeri A Venkatachalam; Anil K Bidani
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

3.  Prospective measurement of glomerular filtration rate and effective renal plasma flow during treatment of malignant essential hypertension.

Authors:  R R Ghose
Journal:  Postgrad Med J       Date:  1984-10       Impact factor: 2.401

4.  Is hypertensive vascular disease reversible?

Authors:  L J Beilin
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

5.  Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension.

Authors:  Aaron J Polichnowski; Karen A Griffin; Maria M Picken; Hector Licea-Vargas; Jianrui Long; Geoffrey A Williamson; Anil K Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-04

6.  Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).

Authors:  A P Aguas; P A Nickerson
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

7.  Excess smoking in malignant-phase hypertension.

Authors:  C Isles; J J Brown; A M Cumming; A F Lever; D McAreavey; J I Robertson; V M Hawthorne; G M Stewart; J W Robertson; J Wapshaw
Journal:  Br Med J       Date:  1979-03-03

8.  Malignant hypertension: cardiac structure and function at presentation and during therapy.

Authors:  L M Shapiro; D G Beevers
Journal:  Br Heart J       Date:  1983-05

9.  The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension.

Authors:  Timothy D Bryson; Teja S Pandrangi; Safa Z Khan; Jiang Xu; Tengis S Pavlov; Pablo A Ortiz; Edward Peterson; Pamela Harding
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

Review 10.  Cardiovascular effects of losartan and its relevant clinical application.

Authors:  Feichao Xu; Caiping Mao; Yali Hu; Can Rui; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.